01-01-2017
Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism
Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2017
Login to get access